Characterization of the tetanus toxin model of refractory focal neocortical epilepsy in the rat

Epilepsia

Volumn 46, Issue 2, 2005, Pages 179-187

  Nilsen, Karen E ^a   Walker, Matthew C ^b   Cock, Hannah R ^a  

^a ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

EEG; Epilepsia partialis continua; Epilepsy; Focal drug application; Refractory cortical epilepsy; Tetanus toxin

Indexed keywords

1,2,3,4 TETRA HYDRO 6 NITRO 2,3 DIOXOBENZO QUINOXALINE 7 SULFONAMIDE; DIAZEPAM; PHENYTOIN; SULFONAMIDE; TETANUS TOXIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BEHAVIOR; CONTROLLED STUDY; ELECTRODE; ELECTROENCEPHALOGRAM; ELECTROMYOGRAPHY; EPILEPTIC STATE; FACE MUSCLE; FOCAL EPILEPSY; MALE; MOTOR CORTEX; MUSCLE TWITCH; MYOCLONUS; NEOCORTEX; NONHUMAN; PRIORITY JOURNAL; RAT; REFRACTORY PERIOD; SEIZURE; SPIKE WAVE;

EID: 13244255203     PISSN: 00139580     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.0013-9580.2005.26004.x     Document Type: Article

References (37)

1. Sander JW. The epidemiology of epilepsy revisited. Curr Opin Neurol 2003;16:165-70.
2. Kojewnikoff AY. Eine besondere Form von corticaler Epilepsie. Neural Zentralbl 1895;14:47-8.
3. Thomas JE, Reagan TJ, Klass DW. Epilepsia partialis continua: a review of 32 cases. Arch Neurol 1977;34:266-75.
4. Stables JP, Bertram E, Dudek FE, et al. Therapy discovery for pharmacoresistant epilepsy and for disease-modifying therapeutics: summary of the NIH/NINDS/AES models II workshop. Epilepsia 2003;44:1472-8.
5. Louis ED, Williamson JM, Darcey TM. Chronic focal epilepsy induced by microinjection of tetanus toxin into the cat motor cortex. Electroencephalogr Clin Neurophysiol 1990;75:548-57.
6. Bergey GK, Bigalke H, Nelson PG. Differential-effects of tetanus toxin on inhibitory and excitatory synaptic transmission in mammalian spinal-cord neurons in culture: a presynaptic locus of action for tetanus toxin. J Neurophysiol 1987;57:121-31.
7. Mellanby H, George G, Robinson A, et al. Epileptiform syndrome in rats produced by injecting tetanus toxin into the hippocampus. J Neurol Neurosurg Psychiatry 1977;40:404-14.
8. Brace HM, Jefferys JGR, Mellanby J. Long-term changes in hippocampal physiology and learning-ability of rats after intrahippocampal tetanus toxin. J Physiol Lond 1985;368:343-57.
9. Jefferys JGR. Chronic epileptic foci in vitro in hippocampal slices from rats with the tetanus toxin epileptic syndrome. J Neurophysiol 1989;62:458-68.
10. Colling SB, Man WDC, Draguhn A, et al. Dendritic shrinkage and dye-coupling between rat hippocampal CA1 pyramidal cells in the tetanus toxin model of epilepsy. Brain Res 1996;741:38-43.
11. Mellanby J, Hawkins C, Mellanby H, et al. Tetanus toxin as a tool for studying epilepsy. J Physiol 1984;79:207-15.
12. Milward AJ, Meldrum BS, Mellanby JH. Forebrain ischaemia with CA1 cell loss impairs epileptogenesis in the tetanus toxin limbic seizure model. Brain 1999;122:1009-16.
13. Vreugdenhil M, Hack SP, Draguhn A, et al. Tetanus toxin induces long-term changes in excitation and inhibition in the rat hippocampal CA1 area. Neuroscience 2002;114:983-94.
14. Mellanby J, Milward AJ. Do fits really beget fits? The effect of previous epileptic activity on the subsequent induction of the tetanus toxin model of limbic epilepsy in the rat. Neurobiol Dis 2001;8:679-91.
15. Rashid S, Lee IG, Anderson AE, et al. Insights into the tetanus toxin model of early-onset epilepsy from long-term video monitoring during anticonvulsant therapy. Dev Brain Res 1999;118:221-5.
16. Lee CL, Hannay J, Hrachovy R, et al. Spatial learning deficits without hippocampal neuronal loss in a model of early-onset epilepsy. Neuroscience 2001;107:71-84.
17. Hagemann G, Hoeller M, Bruehl C, et al. Effects of tetanus toxin on functional inhibition after injection in separate cortical areas in rat. Brain Res 1999;818:127-34.
18. Amitai Y, Gutnick MJ. Chronic epileptogenic effects of tetanus toxin in the neocortex. Munster; Urban & Schwarzenberg, 1991:313-23.
19. Brener K, Amitai Y, Jefferys JGR, et al. Chronic epileptic foci in neocortex: in vivo and in vitro effects of tetanus toxin. Eur J Neurosci 1991;3:47-54.
20. Empson RM, Amitai Y, Jefferys JGR, et al. Injection of tetanus toxin into the neocortex elicits persistent epileptiform activity but only transient impairment of GABA release. Neuroscience 1993;57:235-9.
21. Liang FY, Jones EG. Differential and time-dependent changes in gene expression for type II calcium/calmodulin-dependent protein kinase, 67 kDa glutamic acid decarboxylase, and glutamate receptor subunits in tetanus toxin-induced focal epilepsy. J Neurosci 1997;17:2168-80.
22. Liang FY, Le LD, Jones EG. Reciprocal up- and down-regulation of BDNF mRNA in tetanus toxin-induced epileptic focus and inhibitory surround in cerebral cortex. Cereb Cortex 1998;8:481-91.
23. Paxinos G, Watson C. The rat atlas in stereotaxic co-ordinates. London: Academic Press, 1986.
24. Lees GJ, Leong W. Synergy between diazepam and NBQX in preventing neuronal death caused by non-NMDA agonists. Neuroreport 1994;5:2149-52.
25. Stephen LJ, Kwan P, Brodie MJ. Does the cause of localisation-related epilepsy influence the response to antiepileptic drug treatment? Epilepsia 2001;42:357-62.
26. Biraben A, Chauvel P. Epilepsia partialis continua. In: Engel J, ed. Epilepsy: a comprehensive textbook. Philadelphia: Lippincott Williams & Wilkins, 1997:2447-54.
27. Hamer HM, Luders HO, Knake S, et al. Electrophysiology of focal clonic seizures in humans: a study using subdural and depth electrodes. Brain 2003;126:547-55.
28. Jefferys JG. Chronic epileptic foci induced by intracranial tetanus toxin. In: Heinemann U, ed. Progressive nature of epileptogenesis. Amsterdam: Elsevier Science BV, 1996:111-7.
29. Walker MC, Alavijeh MS, Shorvon SD, et al. Microdialysis study of the neuropharmacokinetics of phenytoin in rat hippocampus and frontal cortex. Epilepsia 1996;37:421-7.
30. Mazarati AM, Baldwin RA, Sankar R, et al. Time-dependent decrease in the effectiveness of antiepileptic drugs during the course of self-sustaining status epilepticus. Brain Res 1998;814:179-85.
31. Craig CR, Coiasanti BK. GABA receptors, lipids, and gangliosides in cobalt epileptic focus. Adv Neurol 1986;44:391.
32. Tamargo RJ, Rossell LA, Kossoff EH, et al. The intracerebral administration of phenytoin using controlled-release polymers reduces experimental seizures in rats. Epilepsy Res 2002;48:145-55.
33. D'Ambrosio R, Fairbanks JP, Fender JS, et al. Post-traumatic epilepsy following fluid percussion injury in the rat. Brain 2004;127:304-14.
34. Lothman EW, Bertram EH, Kapur J, et al. Recurrent spontaneous hippocampal seizures in the rat as a chronic sequela to limbic status epilepticus. Epilepsy Res 1990;6:110-8.
35. Löscher W, Behl B, Seemann D, et al. A new pyrrolylquinoxalinedione series of non-NMDA glutamate receptor antagonists: pharmacological characterization and comparison with NBQX and valproate in the kindling model of epilepsy. Eur J Neurosci 1999;11:250-62.
36. Nilsen KE, Cock HR. Focal treatment for refractory epilepsy: hope for the future? Brain Res Brain Res Rev 2004;44:141-53.
37. Yang XF, Chang JH, Rothman SM. Long-lasting anticonvulsant effect of focal cooling on experimental neocortical seizures. Epilepsia 2003;44:1500-5.